| 1.06 0 (0%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.34 | 1-year : | 1.57 |
| Resists | First : | 1.14 | Second : | 1.35 |
| Pivot price | 1.11 |
|||
| Supports | First : | 0.81 | Second : | 0.68 |
| MAs | MA(5) : | 1.09 |
MA(20) : | 1.06 |
| MA(100) : | 0.99 |
MA(250) : | 1.13 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 31 |
D(3) : | 40.1 |
| RSI | RSI(14): 50.2 | |||
| 52-week | High : | 2.58 | Low : | 0.67 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ BFLY ] has closed above bottom band by 32.7%. Bollinger Bands are 8.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.1 - 1.11 | 1.11 - 1.11 |
| Low: | 1.03 - 1.04 | 1.04 - 1.04 |
| Close: | 1.05 - 1.06 | 1.06 - 1.07 |
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smartphone, tablet, and hospital computer system; and Butterfly Blueprint, a system-wide ultrasound platform with Compass software that integrates into a healthcare system's clinical and administrative infrastructure. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as clinical support and services. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Thu, 25 Jul 2024
Butterfly Network (BFLY) to Release Quarterly Earnings on Thursday - Defense World
Wed, 24 Jul 2024
Multiple Insiders Sold Butterfly Network Shares Presenting Weak Signs For Investors - Simply Wall St
Sun, 21 Jul 2024
Oppenheimer & Co. Inc. Increases Stock Position in Butterfly Network, Inc. (NYSE:BFLY) - Defense World
Thu, 18 Jul 2024
BFLY - Butterfly Network, Inc. Latest Stock News & Market Updates - StockTitan
Thu, 18 Jul 2024
Butterfly Network to Report Second Quarter 2024 Financial Results on August 1, 2024 - StockTitan
Thu, 18 Jul 2024
Butterfly Network to Report Second Quarter 2024 Financial Results on August 1, 2024 - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 184 (M) |
| Shares Float | 156 (M) |
| Held by Insiders | 16.4 (%) |
| Held by Institutions | 35.9 (%) |
| Shares Short | 21,870 (K) |
| Shares Short P.Month | 21,620 (K) |
| EPS | -0.58 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.97 |
| Profit Margin | -179.1 % |
| Operating Margin | -120.5 % |
| Return on Assets (ttm) | -22.6 % |
| Return on Equity (ttm) | -48.8 % |
| Qtrly Rev. Growth | 14.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.36 |
| EBITDA (p.s.) | -0.64 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -76 (M) |
| Levered Free Cash Flow | -18 (M) |
| PE Ratio | -1.83 |
| PEG Ratio | 0 |
| Price to Book value | 1.09 |
| Price to Sales | 2.86 |
| Price to Cash Flow | -2.57 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|